SYK GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Stryker Corp
Exchange: NYSESector: HealthcareIndustry: Medical Devices
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually.
Did you know?
Trading 38% above its estimated fair value of $206.96.
Current Price
$331.54
+0.65%GoodMoat Value
$206.96
37.6% overvaluedProfile
Valuation (TTM)
Market Cap$126.79B
P/E39.06
EV$138.95B
P/B5.66
Shares Out382.42M
P/Sales5.05
Revenue$25.12B
EV/EBITDA24.82
Stryker Corp (SYK) Quality Analysis
SYK Profitability
Profitability trend analysis coming soon
SYK Growth
Growth trend analysis coming soon
SYK Financial Health
Financial health indicators coming soon
SYK Quality & Fundamental Analysis
Stryker Corp (SYK) is a Healthcare company in the Medical Devices industry, listed on NYSE. This quality analysis page evaluates Stryker Corp's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Stryker Corp has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 12.92% and a return on equity (ROE) of 14.48%. Return on assets (ROA) stands at 6.78%.
The debt-to-equity ratio is 0.71, with a current ratio of 1.89. Operating margin is 19.47%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Stryker Corp is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.